Search In this Thesis
   Search In this Thesis  
العنوان
Reck gene polymorphism in patients with hepatocellular carcinoma /
المؤلف
Siddik, Reham Ibrahim.
هيئة الاعداد
باحث / ريهام ابراهيم صديق
مشرف / محمد على مخلص
مشرف / أشرف خميس نصار
مناقش / أمال أحمد محمد
مناقش / نجلاء الطوخى رمضان
الموضوع
Hepatitis C drug therapy. Hepatitis B drug therapy. Drug Resistance, Viral. Carcinoma, Hepatocellula prevention & control.
تاريخ النشر
2018.
عدد الصفحات
210 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الكبد
تاريخ الإجازة
1/1/2018
مكان الإجازة
جامعة بنها - كلية طب بشري - الكبد والجهاز الهضمى
الفهرس
Only 14 pages are availabe for public view

from 210

from 210

Abstract

Liver cancer is the sixth most common cancer and the third cause of cancer related deaths. In Egypt, hepatocellular carcinoma (HCC) has become the second most prevalent cancer among men.Detailed analysis & characterization of molecular, genetic & epi-genetic events would revolutionize early diagnosis of HCC.Gene & protein expression profiling will allow better screening of different stages of HCC as well as establishment of criteria for targeted therapies.The reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) gene is a novel transformation suppressor gene against activated oncogenes.Downregulation of RECK is documented in a wide range of malignant neoplasms (e.g. pancreatic cancer, breast cancer…etc.) and correlates with poor prognosis & tumor metastasis.The aim of this work was to study the association between RECK gene polymorphism and the development of hepatocellular carcinoma in patients with liver cirrhosis.This study was conducted on 115 individuals. The patients were recruited from outpatient clinic and/or inpatient Department of Hepatology, Gastroenterology & Infectious Diseases, Benha faculty of Medicine, and from the outpatient clinic of the National Research Center.